Hematologist
CION Cancer Clinics
When CMV wakes up after a stem cell transplant | CION Cancer Clinics
CMV reactivation means a common virus that has been sleeping in your body has become active because your immune system is weak after the transplant. It is common after a donor transplant, is usually found on a routine blood test before any symptoms, and is treatable. A positive test is not the same as CMV disease. Here is how it is watched, how it is treated, and when to call. At CION Cancer Clinics, our haematology team assesses whether a transplant or CAR-T fits your situation and coordinates care with qualified centres.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does CMV reactivation after a transplant mean?
- How do doctors find and follow CMV?
- Is CMV in the blood the same as CMV disease?
- How is CMV reactivation treated?
- What do families often get wrong about CMV?
- What do the words on a CMV report mean?
- What can this page not tell you about your own CMV result?
- Common questions about CMV after a transplant
The short answer
What does CMV reactivation after a transplant mean?
CMV reactivation means a common virus that was sleeping quietly in your body, or in your donor's cells, has become active again because the immune system is weak after the transplant. It is common, it is usually found on a routine blood test before any symptoms, and it is treatable.
What CMV is
Cytomegalovirus, or CMV, is a virus from the same family as chickenpox. Most adults in India caught it in childhood without noticing. Once caught, it stays in the body for life, kept asleep by a healthy immune system.
Why transplants wake it up
A donor transplant, and the medicines that prevent graft-versus-host disease (GVHD), leave the immune system too weak to keep CMV asleep. The risk is highest in the first months after a donor transplant, and whenever GVHD needs stronger treatment. It is much less common after a transplant using your own cells.
Why teams take it seriously
Left to grow, CMV can damage the lungs, gut, liver or eyes, and it can lower blood counts. That is why teams test for it regularly and treat early, rather than waiting for illness.
A positive CMV blood test is not the same as being ill with CMV. Most people found this way never develop CMV disease.How it is watched
How do doctors find and follow CMV?
Checking before the transplant
An antibody test shows whether you and your donor have ever had CMV. This sets how closely you will be watched afterwards.
Regular blood tests
After a donor transplant, a PCR blood test counts the virus in the blood, often weekly in the early months. Some people also take a medicine to prevent reactivation in this period.
Treating a rising level
If the level crosses your centre's threshold or keeps rising, the team starts antiviral treatment early. This is called pre-emptive treatment.
Testing until it clears
Tests continue during treatment until the level is low or not detected on repeat tests. Monitoring then carries on, because CMV can come back.
Not sure whether this applies to you?
Ask an oncologistTwo different things
Is CMV in the blood the same as CMV disease?
CMV in the blood (reactivation)
CMV disease
Virus detected on a PCR blood test
Virus damaging an organ such as the lungs, gut, liver or eyes
Often no symptoms at all
Symptoms such as fever, breathlessness, loose motions or blurred vision
Usually treated as an outpatient
Often needs a hospital stay and extra tests such as a scope or scan
Common after a donor transplant
Much less common where regular testing is done
Treatment
How is CMV reactivation treated?
Your team chooses the medicine, the length of treatment and the dose. None of it should be started or changed on your own.
Preventing reactivation
Some people who carry CMV are given letermovir after a donor transplant to lower the chance of the virus waking up in the early months. Not every centre or patient uses it.
First-line antivirals
Ganciclovir through a vein, or valganciclovir as tablets, are commonly used when the level rises. They can lower white cell counts, so blood counts are checked closely.
If the first choice does not suit
Foscarnet, maribavir or other options may be used if counts are too low or the virus does not respond.
Things the team watches
- Kidney function and salts in the blood
- Whether the virus has become resistant
Adjusting other medicines
Where possible, the team may reduce steroids or other immune-suppressing medicines. This is balanced against the risk of GVHD, and only your team decides it.
Commonly believed
What do families often get wrong about CMV?
"CMV positive means the transplant has failed."
No. CMV reactivation is one of the most common events after a donor transplant. It says the immune system is still weak, which is expected. It says nothing on its own about whether the transplant is working.
"We caught it from the hospital or from a visitor."
Most reactivation comes from virus already in your body or in the donor's cells. Blaming a relative or the ward does not help. Good hygiene still matters for other infections.
"He feels fine, so the tablets can stop early."
CMV often causes no symptoms. Stopping early lets the virus climb again. Treatment stops when the blood tests say so and the team agrees.
"Family members should stay away from a CMV positive patient."
Healthy adults are very unlikely to be harmed. Pregnant women and newborns are the exception. Ask the team about precautions if someone at home is pregnant.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
What do the words on a CMV report mean?
- CMV IgG positive
- You have had CMV at some point in the past. It says nothing about whether it is active now.
- CMV PCR or DNA test
- A blood test that looks for the virus's genetic material and measures how much is present.
- Viral load
- The amount of virus found in the blood sample. The trend between tests matters more than one figure.
- Not detected
- No virus found in that sample. Monitoring usually still continues.
- Pre-emptive treatment
- Treatment started because the level is rising, before any organ is affected.
Being straight with you
What can this page not tell you about your own CMV result?
This page cannot tell you whether your own CMV level needs treatment. Labs report the viral load in different units, and each transplant centre sets its own threshold for acting. The same number can be watched in one person and treated in another, depending on GVHD, steroids, counts and the trend.
When to call the team the same day
Call at once if there is a fever, new breathlessness or cough, loose motions that do not settle, stomach pain, or new blurred vision or floaters in the eyes. These can be signs that CMV, or another infection, is affecting an organ. If you cannot reach the team, go to the nearest emergency department.
Questions worth asking
What level would make you treat? How often will you test? Which side effects of the medicine should we watch for, and when will you check the counts and kidneys? CION's haematology team can go through CMV reports with you and help you prepare these questions for your transplant centre.
Questions we are asked
Common questions about CMV after a transplant
Is CMV reactivation dangerous?
It can be if it is missed and allowed to spread to organs. When it is found early on routine blood tests and treated, most people recover from it without lasting harm. That is why keeping every blood test appointment in the first months matters so much.
Can CMV come back after treatment?
Yes. Because the virus stays in the body for life, it can reactivate more than once, especially while immune-suppressing medicines or steroids continue. Repeat episodes are usually handled the same way. Your team will keep testing for as long as the risk remains.
Does CMV reactivation happen after an autologous transplant?
It can, but it is much less common, because your own immune cells were returned and recover faster. Many centres do not test routinely after a transplant using your own cells unless there are symptoms or other risk factors. Ask your team what they plan.
Will I need to be admitted for treatment?
Not always. Tablets can often be taken at home with regular blood tests. Treatment through a vein, very low counts, or signs of CMV disease in an organ may mean a hospital or day-care stay. Your team will decide based on your counts and how you are.
Why are my blood counts dropping on CMV treatment?
Some CMV medicines, and CMV itself, can lower white cells and platelets. The team checks counts often and may change the medicine or add support. Do not stop the medicine yourself; call the team if you get a fever, bleeding or unusual bruising.
Is the CMV medicine expensive?
Some of these medicines are costly, and prices change. Coverage under insurance, Aarogyasri, CGHS, ECHS, EHS or PM-JAY depends on the scheme and whether treatment is given as an inpatient. Check the current rules with your insurer or the scheme desk before treatment starts.
Can my donor's CMV status affect me?
Yes. Whether you and your donor have had CMV is one of the things that sets your risk. Transplant teams consider it when choosing between suitable donors, and it guides how closely you are tested afterwards.
Is it safe to be near a pregnant family member?
Usually, with sensible hygiene: handwashing, not sharing cups or utensils, and not kissing on the mouth. CMV can harm an unborn baby, so tell the team if someone at home is pregnant and ask whether any extra care is needed.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- NHS — Cytomegalovirus (CMV)
- National Cancer Institute — Stem Cell Transplants in Cancer Treatment
- American Cancer Society — Stem Cell or Bone Marrow Transplant
- Leukemia & Lymphoma Society — Stem Cell Transplantation
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Infection Risk in the First Year After TransplantThe wider picture of infection after transplantThe First 100 Days After TransplantWhen CMV testing is most frequentDay +100 Assessment: What Gets CheckedWhere virus checks fit in the reviewLife After TransplantEvery guide for the months and years ahead
Talk to us
Have a CMV result you are unsure about?
Share it with us. CION's haematology team will explain it and help you prepare questions for your transplant centre. One helpline serves every CION centre.